Jump Financial, LLC Invitae Corp Transaction History

Jump Financial, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 07, 2023	BUY	$1.05 - $1.63 $19,332 - $30,011	18,412 Added 17.99%	120,776 $136,000
Q1 2023 May 03, 2023	BUY	$1.2 - $2.73 $122,836 - $279,453	102,364 New	102,364 $138,000
Q3 2022 Nov 07, 2022	SELL	$1.9 - $8.63 $456,171 - $2.07 Million	-240,090 Reduced 95.05%	12,511 $31,000
Q2 2022 Aug 09, 2022	BUY	$2.13 - $9.01 $538,040 - $2.28 Million	252,601 New	252,601 $616,000
Q4 2021 Feb 10, 2022	SELL	$14.7 - $28.67 $1.24 Million - $2.41 Million	-84,117 Closed	0 $0

Q3 2021 Nov 12, 2021	BUY	$24.31 - $33.6 $2.04 Million - $2.83 Million	84,117 New	84,117 $2.39 Million
Q4 2020 Feb 12, 2021	SELL	$39.09 - $57.4 $906,888 - $1.33 Million	-23,200 Closed	0 $0
Q3 2020 Nov 13, 2020	BUY	$28.43 - $44.67 $659,576 - $1.04 Million	23,200 New	23,200 $1.01 Million

7.66M

Ticker NVTA
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 235,266,000
Description
Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and...

Get notified when there are updates to the investment portfolio of Jump Financial, LLC, based on Form 13F filings with the SEC.

Stay updated on Jump Financial, LLC with notifications on news.